Valirx News (LSE:VAL)

Latest Valirx News Headlines
DateTimeSource
Headline
09/28/20092:40AMUKREGHalf Yearly Report
TIDMVAL RNS Number : 7382Z ValiRx PLC 28 September 2009 ? ValiRx plc Unaudited interim results for the six months ended 30 June 2009 28 September 2009, London. ValiRx plc (AIM: VAL, 'ValiRx', 'the Company) the cancer therapeutics and diagnostics company, announces its unaudited interim results for the... More...>>
09/14/20092:00AMUKREGNew Distribution Venture & Trading Platform Launch
TIDMVAL RNS Number : 9690Y ValiRx PLC 14 September 2009 ? ValiRx plc (the "Company") New distribution venture and Trading platform launch The Company is pleased to announce the creation of a new wholly owned trading subsidiary to be known as ValiMedix Limited ("ValiMedix"). ValiMedix... More...>>
07/29/20093:06AMUKREGAustralian Patent Acceptance
TIDMVAL RNS Number : 4555W ValiRx PLC 29 July 2009 ? ValiRx plc ("ValiRx" or the "Company") Australian patent acceptance for lead GeneICE compound The Company is pleased to announce that it has received acceptance from the Australian Patent Office for the patent application relating to the Company's... More...>>
07/03/20095:57AMUKREGResult of AGM
TIDMVAL RNS Number : 0855V ValiRx PLC 03 July 2009 ? ValiRx plc (the "Company") Result of Annual General Meeting The Company is pleased to announce that all resolutions put to shareholders at today's annual general meeting of the Company were duly approved. For more information please contact:... More...>>
06/10/20098:35AMUKREGFinal Results
TIDMVAL RNS Number : 6835T ValiRx PLC 10 June 2009 ? VALIRX PLC ("VALIRX" OR THE "COMPANY") FINAL RESULTS FOR THE TWELVE MONTHS ENDED 31 DECEMBER 2008 ValiRx (AIM: VAL), the cancer therapeutics and diagnostics company, today announces its final results for the twelve month period ended 31 December 2008... More...>>
06/10/20093:50AMUKREGAward for cancer therapeutics project
TIDMVAL RNS Number : 6520T ValiRx PLC 10 June 2009 ? ValiRx plc ("ValiRx" or "the Company") Award for cancer therapeutics project ValiRx plc (ValiRx or "the Company"), the biopharmaceutical company focused on the discovery and development of epigenomic platforms for the treatment and diagnosis... More...>>
05/29/20092:00AMUKREGPlacing Summary and Total Voting Rights
TIDMVAL RNS Number : 8955S ValiRx PLC 29 May 2009 ? ValiRx plc (the "Company") Placing Summary & Total Voting Rights Placing Summary The Company is pleased to announce that the recent placing of ordinary shares of 1p each in the Company ("Ordinary Shares") raised, in aggregate, GBP978,999.98... More...>>
05/11/20092:00AMUKREGIssue of Equity
TIDMVAL RNS Number : 9660R ValiRx PLC 11 May 2009 ? ValiRx plc (the "Company") Issue of equity Further to the announcement on 5 May, 2009, the Company is pleased to confirm that it has raised GBP199,999.98, before expenses, via a placing of 16,666,665 new ordinary shares of 1p each in the Company... More...>>
05/05/20098:00AMUKREGIssue of Equity
TIDMVAL RNS Number : 6874R ValiRx PLC 05 May 2009 ? ValiRx plc (the "Company") Issue of equity Following the recent placing of new ordinary shares of 1p each in the Company ("Ordinary Shares"), the Company is pleased to announce that it has received further interest from investors. As a result... More...>>
04/30/20092:00AMUKREGTotal Voting Rights
TIDMVAL RNS Number : 3426R ValiRx PLC 30 April 2009 ? ValiRx plc (the "Company") Total Voting Rights For the purposes of the transitional provisions of the Financial Services Authority's Disclosure and Transparency Rules, the total number of ordinary shares of 1p each in the capital of the Company... More...>>
04/27/20092:00AMUKREGIssue of Equity
TIDMVAL RNS Number : 1650R ValiRx PLC 27 April 2009 ? ValiRx plc (the "Company") Issue of equity The Company announces that it has issued 200,000 new ordinary shares of 1p each in the Company ("Ordinary Shares") at 1p per share pursuant to an agreement to issue Ordinary Shares in lieu of services... More...>>
04/16/200910:05AMUKREGHolding(s) in Company
TIDMVAL RNS Number : 6989Q ValiRx PLC 16 April 2009 ? ValiRx plc (the "Company") Notice of interest Further to the placing of 19,900,000 new ordinary shares of 1p each in the Company ("Ordinary Shares"), admitted to trading on AIM today, the Company confirms that it has today been advised by... More...>>
04/16/20092:00AMUKREGIssue of Equity
TIDMVAL RNS Number : 6149Q ValiRx PLC 16 April 2009 ? ValiRx plc (the "Company") Issue of equity Further to the announcement on 9 April, 2009, the Company is pleased to confirm that it has raised GBP199,000, before expenses, via a placing of 19,900,000 new ordinary shares of 1p each in the... More...>>
04/09/20092:00AMUKREGIssue of Equity
TIDMVAL RNS Number : 3895Q ValiRx PLC 09 April 2009 ? ValiRx plc (the "Company") Issue of equity Following the placing of new ordinary shares of 1p each in the Company ("Ordinary Shares"), announced on 31 March, 2009, the Company is pleased to announce that it has received further interest... More...>>
04/06/20094:59AMUKREGHolding(s) in Company
TIDMVAL RNS Number : 1832Q ValiRx PLC 06 April 2009 ? ValiRx plc (the "Company") Notice of interest Further to the placing of 58,000,000 new ordinary shares of 1p each in the Company ("Ordinary Shares"), announced on 31 March, 2009 (the "Placing"), the Company confirms that, on 3 April, 2009... More...>>
03/31/20092:00AMUKREGUpdate to the Sale of Shares Agreement
TIDMVAL RNS Number : 7531P ValiRx PLC 31 March 2009 ? ValiRx plc (the "Company") Update to the Sale of Shares Agreement The Company announces that it has agreed amended payment terms with Biofield Corp ("Biofield") for the payment of Eur 600,000 as consideration due to the Company following... More...>>
03/31/20092:00AMUKREGIssue of Equity and Directors' Shareholdings
TIDMVAL RNS Number : 7525P ValiRx PLC 31 March 2009 ? ValiRx plc (the "Company") Issue of Equity and Directors' Shareholdings The Company announces that it has conditionally raised GBP580,000, before expenses, via a placing of 58,000,000 new ordinary shares of 1p each in the Company ("Ordinary... More...>>
03/12/20093:00AMUKREGValiRx Announces Promising In Vivo Data
TIDMVAL RNS Number : 7251O ValiRx PLC 12 March 2009 ? ValiRx plc ValiRx Announces Promising In Vivo Data for Therapeutic Cancer Compound VAL 101, Based on its Gene Silencing GeneICE(TM) Technology Platform 12 March 2009, London: ValiRx plc (AIM:VAL, "ValiRx" or the "Company"), the cancer therapeutics... More...>>
02/27/20092:00AMUKREGTotal Voting Rights
TIDMVAL RNS Number : 8822N ValiRx PLC 27 February 2009 ? ValiRx plc (the "Company") Total Voting Rights For the purposes of the transitional provisions of the Financial Services Authority's Disclosure and Transparency Rules, following the reorganisation of the Company's share capital announced... More...>>
02/13/20095:52AMUKREGResult of EGM
TIDMVAL RNS Number : 2902N ValiRx PLC 13 February 2009 ? 13 February 2009 ValiRx plc Result of General Meeting ValiRx plc (AIM:VAL, 'ValiRx', 'The Company') announces that at the general meeting of the Company held earlier today the special resolution put to shareholders to approve the Proposed... More...>>


LSE and PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme
Copyright1999-2009 ADVFN PLC. Copyright and limited reproduction :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs
ADDITIONAL SERVICES AVAILABLE FROM ADVFN
Upgrade - Click here for more information on ADVFN premium services Money Words - ADVFN Financial Glossary Investor Training ADVFN Financial Bookshop Online Training Academy
31 site:2us lse val091123 19:27 Stock Message Boards ( 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 )